Literature DB >> 5580751

Newborn screening for hereditary metabolic disorders in Manitoba, 1965-1970.

J G Fox, D L Hall, J C Haworth, A Maniar, L Sekla.   

Abstract

The newborn screening program for hereditary metabolic disorders in Manitoba is reviewed. In 1965, screening was begun on infants born in Metropolitan Winnipeg, and since January 1966 screening has been provincewide. Bloods from 85,868 infants have been screened so far. For the past two-and-a-half years 98.5% of live-born infants surviving the first seven days of life have been screened.The Guthrie bacterial inhibition test was used initially. In 1966 an evaluation was undertaken of one-dimensional amino-acid paper chromatography, and in 1969 this method replaced the Guthrie test. Five cases of phenylketonuria have been identified, and incidence of 1:17, 174. Screening for abnormal sugars in the blood has disclosed two cases of galactosemia. The incidence of galactosemia in the province is 1 in 16,069 live births.

Entities:  

Mesh:

Year:  1971        PMID: 5580751      PMCID: PMC1931040     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  14 in total

1.  Children of mothers with phenylketonuria.

Authors:  J S Yu; M T O'Halloran
Journal:  Lancet       Date:  1970-01-31       Impact factor: 79.321

Review 2.  Phenylketonuria 1967.

Authors:  D Y Hsia
Journal:  Dev Med Child Neurol       Date:  1967-10       Impact factor: 5.449

3.  Maternal phenylketonuria. Detrimental effects on embryogenesis and fetal development.

Authors:  R O Fisch; D Doeden; L L Lansky; J A Anderson
Journal:  Am J Dis Child       Date:  1969-12

4.  A prospective community survey for aminoacidaemias.

Authors:  G M Komrower; M J Griffiths; B Fowler; A M Lambert
Journal:  Proc R Soc Med       Date:  1968-03

5.  Transient tyrosinemia in full-term infants.

Authors:  H L Levy; V E Shih; P M Madigan; R A MacCready
Journal:  JAMA       Date:  1969-07-14       Impact factor: 56.272

6.  Screening for galactosemia in New York State.

Authors:  S Kelly; S Katz; J Burns; J Boylan
Journal:  Public Health Rep       Date:  1970-07       Impact factor: 2.792

7.  A simple chromatographic screening test for the detection of galactosemia in newborn infants.

Authors:  J C Haworth; N H Barchuk
Journal:  Pediatrics       Date:  1967-04       Impact factor: 7.124

8.  Aminoacidemia of prematurity. Its response to ascorbic acid.

Authors:  I J Light; H K Berry; J M Sutherland
Journal:  Am J Dis Child       Date:  1966-09

9.  Tyrosinaemia and tyrosyluria in infancy.

Authors:  P W Wong; A M Lambert; G M Komrower
Journal:  Dev Med Child Neurol       Date:  1967-10       Impact factor: 5.449

10.  Effect of elevated blood tyrosine on subsequent intellectual development of premature infants.

Authors:  J H Menkes; V Chernick; B Ringel
Journal:  J Pediatr       Date:  1966-10       Impact factor: 4.406

View more
  5 in total

1.  Newborn screening in North America.

Authors:  Bradford L Therrell; John Adams
Journal:  J Inherit Metab Dis       Date:  2007-07-23       Impact factor: 4.982

2.  Experience of the Manitoba Perinatal Screening Program, 1965-85.

Authors:  J G Fox
Journal:  CMAJ       Date:  1987-11-15       Impact factor: 8.262

3.  Screening, counselling and treatment of hereditary metabolic disease; a survey of resources in Canada.

Authors:  J C Haworth; J R Miller; C R Scriver
Journal:  Can Med Assoc J       Date:  1974-11-16       Impact factor: 8.262

4.  Incidence of phenylketonuria in British Columbia, 1950-1971.

Authors:  R B Lowry; B Tischler; W H Cockcroft; D H Renwick
Journal:  Can Med Assoc J       Date:  1972-06-24       Impact factor: 8.262

5.  Global prevalence of classic phenylketonuria based on Neonatal Screening Program Data: systematic review and meta-analysis.

Authors:  Hamid Reza Shoraka; Ali Akbar Haghdoost; Mohammad Reza Baneshi; Zohre Bagherinezhad; Farzaneh Zolala
Journal:  Clin Exp Pediatr       Date:  2020-02-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.